Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date | Reported DateTime | Company | Symbol | Insider Relationship | Shares Traded | Average Price | Total Amount | Shares Owned | Filing |
| 2026-10-01 Sale | 2026-10-05 5:36 pm | Tango Therapeutics Inc. | TNGX | Crystal Adam President, R&D | 27,000 | $24.47 | $660,796 | 348,783 (Direct) | View |
| 2026-09-01 Sale | 2026-09-03 4:01 pm | Tango Therapeutics Inc. | TNGX | Crystal Adam President, R&D | 27,000 | $22.37 | $603,909 | 375,783 (Direct) | View |
| 2026-08-03 Sale | 2026-08-05 4:01 pm | Tango Therapeutics Inc. | TNGX | Crystal Adam President, R&D | 27,000 | $27.24 | $735,517 | 402,783 (Direct) | View |
| 2026-07-01 Sale | 2026-07-02 7:23 pm | Tango Therapeutics Inc. | TNGX | Crystal Adam President, R&D | 27,000 | $29.59 | $798,908 | 429,783 (Direct) | View |
| 2026-06-01 Sale | 2026-06-03 6:37 pm | Tango Therapeutics Inc. | TNGX | Crystal Adam President, R&D | 27,000 | $22.87 | $617,571 | 456,783 (Direct) | View |
| 2026-05-01 Sale | 2026-05-05 7:47 pm | Tango Therapeutics Inc. | TNGX | Crystal Adam President, R&D | 27,000 | $21.23 | $573,097 | 483,783 (Direct) | View |
| 2026-04-15 Sale | 2026-04-16 8:14 pm | Tango Therapeutics Inc. | TNGX | Crystal Adam President, R&D | 38,460 | $25 | $961,500 | 507,662 (Direct) | View |
| 2026-04-01 Sale | 2026-04-02 8:09 pm | Tango Therapeutics Inc. | TNGX | Crystal Adam President, R&D | 27,000 | $21.2 | $572,478 | 546,122 (Direct) | View |
| 2026-03-25 Sale | 2026-03-27 8:06 pm | Tango Therapeutics Inc. | TNGX | Crystal Adam President, R&D | 12,000 | $20.11 | $241,320 | 573,122 (Direct) | View |
| 2026-03-05 Sale | 2026-03-09 4:01 pm | Tango Therapeutics Inc. | TNGX | Crystal Adam President, R&D | 20,251 | $15 | $303,765 | 112,622 (Direct) | View |
| 2026-02-25 Sale | 2026-02-27 6:54 pm | Tango Therapeutics Inc. | TNGX | Crystal Adam President, R&D | 54,345 | $12.77 | $694,208 | 132,873 (Direct) | View |
| 2026-02-03 Sale | 2026-02-04 8:02 pm | Tango Therapeutics Inc. | TNGX | Crystal Adam President, R&D | 18,452 | $12.26 | $226,300 | 471,978 (Direct) | View |
| 2025-02-04 Sale | 2025-02-06 8:08 pm | Tango Therapeutics Inc. | TNGX | Crystal Adam See Remarks | 14,283 | $3.0712 | $43,866 | 158,210 (Direct) | View |
| 2024-02-06 Sale | 2024-02-08 9:04 pm | Tango Therapeutics Inc. | TNGX | Crystal Adam See Remarks | 8,371 | $12.59 | $105,395 | 119,478 (Direct) | View |
| 2023-11-01 Sale | 2023-11-02 4:49 pm | Tango Therapeutics Inc. | TNGX | Crystal Adam See Remarks | 7,507 | $8.3914 | $62,994 | 81,250 (Direct) | View |
| 2022-01-04 Sale | 2022-01-05 4:30 pm | C4 Therapeutics Inc. | CCCC | Crystal Adam Chief Medical Officer | 15,000 | $31.66 | $474,968 | 127,292 (Direct) | View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date | Reported DateTime | Exercisable Expiration | Company | Symnbol | Insider Relationship | Shares Traded | Conversion Price | Shares Owned | Filing |
| 2026-10-01 Exercise | 2026-10-05 5:36 pm | N/A 2033-03-01 | Tango Therapeutics Inc. | TNGX | Crystal Adam President, R&D | 27,000 | $0 | 348,783 (Direct) | View |
| 2026-10-01 Exercise | 2026-10-05 5:36 pm | N/A N/A | Tango Therapeutics Inc. | TNGX | Crystal Adam President, R&D | 27,000 | $5.2 | 348,783 (Direct) | View |
| 2026-09-01 Exercise | 2026-09-03 4:01 pm | N/A 2033-03-01 | Tango Therapeutics Inc. | TNGX | Crystal Adam President, R&D | 27,000 | $0 | 375,783 (Direct) | View |
| 2026-09-01 Exercise | 2026-09-03 4:01 pm | N/A N/A | Tango Therapeutics Inc. | TNGX | Crystal Adam President, R&D | 27,000 | $5.2 | 375,783 (Direct) | View |
| 2026-08-03 Exercise | 2026-08-05 4:01 pm | N/A 2033-03-01 | Tango Therapeutics Inc. | TNGX | Crystal Adam President, R&D | 27,000 | $0 | 402,783 (Direct) | View |
| 2026-08-03 Exercise | 2026-08-05 4:01 pm | N/A N/A | Tango Therapeutics Inc. | TNGX | Crystal Adam President, R&D | 27,000 | $5.2 | 402,783 (Direct) | View |
| 2026-07-01 Exercise | 2026-07-02 7:23 pm | N/A 2033-03-01 | Tango Therapeutics Inc. | TNGX | Crystal Adam President, R&D | 27,000 | $0 | 429,783 (Direct) | View |
| 2026-07-01 Exercise | 2026-07-02 7:23 pm | N/A N/A | Tango Therapeutics Inc. | TNGX | Crystal Adam President, R&D | 27,000 | $5.2 | 429,783 (Direct) | View |
| 2026-06-01 Exercise | 2026-06-03 6:37 pm | N/A 2033-03-01 | Tango Therapeutics Inc. | TNGX | Crystal Adam President, R&D | 27,000 | $0 | 456,783 (Direct) | View |
| 2026-06-01 Exercise | 2026-06-03 6:37 pm | N/A N/A | Tango Therapeutics Inc. | TNGX | Crystal Adam President, R&D | 27,000 | $5.2 | 456,783 (Direct) | View |
| 2026-05-01 Exercise | 2026-05-05 7:47 pm | N/A 2033-03-01 | Tango Therapeutics Inc. | TNGX | Crystal Adam President, R&D | 27,000 | $0 | 483,783 (Direct) | View |
| 2026-05-01 Exercise | 2026-05-05 7:47 pm | N/A N/A | Tango Therapeutics Inc. | TNGX | Crystal Adam President, R&D | 27,000 | $5.2 | 483,783 (Direct) | View |
| 2026-04-15 Exercise | 2026-04-16 8:14 pm | N/A 2033-03-01 | Tango Therapeutics Inc. | TNGX | Crystal Adam President, R&D | 38,460 | $0 | 507,662 (Direct) | View |
| 2026-04-15 Exercise | 2026-04-16 8:14 pm | N/A N/A | Tango Therapeutics Inc. | TNGX | Crystal Adam President, R&D | 38,460 | $5.2 | 507,662 (Direct) | View |
| 2026-04-01 Exercise | 2026-04-02 8:09 pm | N/A 2033-03-01 | Tango Therapeutics Inc. | TNGX | Crystal Adam President, R&D | 27,000 | $0 | 546,122 (Direct) | View |
| 2026-04-01 Exercise | 2026-04-02 8:09 pm | N/A N/A | Tango Therapeutics Inc. | TNGX | Crystal Adam President, R&D | 27,000 | $5.2 | 546,122 (Direct) | View |
| 2026-03-25 Exercise | 2026-03-27 8:06 pm | N/A 2033-03-01 | Tango Therapeutics Inc. | TNGX | Crystal Adam President, R&D | 12,000 | $0 | 573,122 (Direct) | View |
| 2026-03-25 Exercise | 2026-03-27 8:06 pm | N/A N/A | Tango Therapeutics Inc. | TNGX | Crystal Adam President, R&D | 12,000 | $5.2 | 573,122 (Direct) | View |
| 2026-02-02 Option Award | 2026-02-04 8:02 pm | N/A 2036-02-02 | Tango Therapeutics Inc. | TNGX | Crystal Adam President, R&D | 332,220 | $0 | 471,978 (Direct) | View |
| 2025-02-03 Option Award | 2025-02-05 7:34 pm | N/A 2035-02-03 | Tango Therapeutics Inc. | TNGX | Crystal Adam See Remarks | 371,105 | $0 | 490,583 (Direct) | View |
| 2024-02-01 Option Award | 2024-02-05 4:22 pm | N/A 2034-02-01 | Tango Therapeutics Inc. | TNGX | Crystal Adam See Remarks | 326,192 | $0 | 326,192 (Direct) | View |
| 2023-03-01 Option Award | 2023-03-02 4:10 pm | N/A 2033-03-01 | Tango Therapeutics Inc. | TNGX | Crystal Adam See Remarks | 568,750 | $0 | 568,750 (Direct) | View |
| 2023-01-30 Tax Withholding | 2023-02-01 4:11 pm | N/A N/A | C4 Therapeutics Inc. | CCCC | Crystal Adam Chief Medical Officer | 1,301 | $7.78 | 38,847 (Direct) | View |
| 2023-01-30 Exercise | 2023-02-01 4:11 pm | N/A 2025-02-28 | C4 Therapeutics Inc. | CCCC | Crystal Adam Chief Medical Officer | 3,750 | $0 | 38,847 (Direct) | View |
| 2022-05-26 Tax Withholding(A) | 2022-06-14 4:45 pm | N/A N/A | C4 Therapeutics Inc. | CCCC | Crystal Adam Chief Medical Officer | 1,102 | $7.01 | 17,648 (Direct) | View |
| 2022-05-25 Exercise | 2022-05-27 4:16 pm | N/A 2025-02-28 | C4 Therapeutics Inc. | CCCC | Crystal Adam Chief Medical Officer | 3,750 | $0 | 41,250 (Direct) | View |
| 2022-02-14 Option Award | 2022-02-16 4:30 pm | N/A 2032-02-13 | C4 Therapeutics Inc. | CCCC | Crystal Adam Chief Medical Officer | 144,250 | $0 | 144,250 (Direct) | View |
| 2022-01-04 Exercise | 2022-01-05 4:30 pm | N/A 2029-04-08 | C4 Therapeutics Inc. | CCCC | Crystal Adam Chief Medical Officer | 15,000 | $0 | 127,292 (Direct) | View |
| 2022-01-04 Exercise | 2022-01-05 4:30 pm | N/A N/A | C4 Therapeutics Inc. | CCCC | Crystal Adam Chief Medical Officer | 15,000 | $6.49 | 127,292 (Direct) | View |
| 2021-12-22 Exercise | 2021-12-23 4:10 pm | N/A 2029-04-08 | C4 Therapeutics Inc. | CCCC | Crystal Adam Chief Medical Officer | 5,000 | $0 | 142,292 (Direct) | View |
| 2021-12-22 Exercise | 2021-12-23 4:10 pm | N/A N/A | C4 Therapeutics Inc. | CCCC | Crystal Adam Chief Medical Officer | 5,000 | $6.49 | 142,292 (Direct) | View |